Literature DB >> 20687469

DNA damage and polyploidization.

Jeremy Chow1, Randy Y C Poon.   

Abstract

A growing body of evidence indicates that polyploidization triggers chromosomal instability and contributes to tumorigenesis. DNA damage is increasingly being recognized for its roles in promoting polyploidization. Although elegant mechanisms known as the DNA damage checkpoints are responsible for halting the cell cycle after DNA damage, agents that uncouple the checkpoints can induce unscheduled entry into mitosis. Likewise, defects of the checkpoints in several disorders permit mitotic entry even in the presence of DNA damage. Forcing cells with damaged DNA into mitosis causes severe chromosome segregation defects, including lagging chromosomes, chromosomal fragments and chromosomal bridges. The presence of these lesions in the cleavage plane is believed to abort cytokinesis. It is postulated that if cytokinesis failure is coupled with defects of the p53-dependent postmitotic checkpoint pathway, cells can enter S phase and become polyploids. Progress in the past several years has unraveled some of the underlying principles of these pathways and underscored the important role of DNA damage in polyploidization. Furthermore, polyploidization per se may also be an important determinant of sensitivity to DNA damage, thereby may offer an opportunity for novel therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687469     DOI: 10.1007/978-1-4419-6199-0_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors.

Authors:  Andrea Acebes-Huerta; Seila Lorenzo-Herrero; Alicia R Folgueras; Leticia Huergo-Zapico; Carlos Lopez-Larrea; Alejandro López-Soto; Segundo Gonzalez
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

2.  Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.

Authors:  Douglas R Stewart; Alexander Pemov; Peter Van Loo; Eline Beert; Hilde Brems; Raf Sciot; Kathleen Claes; Evgenia Pak; Amalia Dutra; Chyi-Chia Richard Lee; Eric Legius
Journal:  Genes Chromosomes Cancer       Date:  2012-01-17       Impact factor: 5.006

3.  Uracil DNA N-glycosylase promotes assembly of human centromere protein A.

Authors:  Samantha G Zeitlin; Brian R Chapados; Norman M Baker; Caroline Tai; Geir Slupphaug; Jean Y J Wang
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

Review 4.  Against Lung Cancer Cells: To Be, or Not to Be, That Is the Problem.

Authors:  Naoko Okumura; Hitomi Yoshida; Yasuko Kitagishi; Yuri Nishimura; Shio Iseki; Satoru Matsuda
Journal:  Lung Cancer Int       Date:  2012-02-01

5.  Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.

Authors:  Zhengyan Kan; Hancheng Zheng; Xiao Liu; Shuyu Li; Thomas D Barber; Zhuolin Gong; Huan Gao; Ke Hao; Melinda D Willard; Jiangchun Xu; Robert Hauptschein; Paul A Rejto; Julio Fernandez; Guan Wang; Qinghui Zhang; Bo Wang; Ronghua Chen; Jian Wang; Nikki P Lee; Wei Zhou; Zhao Lin; Zhiyu Peng; Kang Yi; Shengpei Chen; Lin Li; Xiaomei Fan; Jie Yang; Rui Ye; Jia Ju; Kai Wang; Heather Estrella; Shibing Deng; Ping Wei; Ming Qiu; Isabella H Wulur; Jiangang Liu; Mariam E Ehsani; Chunsheng Zhang; Andrey Loboda; Wing Kin Sung; Amit Aggarwal; Ronnie T Poon; Sheung Tat Fan; Jun Wang; James Hardwick; Christoph Reinhard; Hongyue Dai; Yingrui Li; John M Luk; Mao Mao
Journal:  Genome Res       Date:  2013-06-20       Impact factor: 9.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.